Excitingly, in vivo studies have revealed that CA4 is a vascular disrupting agent (VDA), which is a classification that refers to compounds that can destroy newly formed vasculature, such as found in tumour environments [2, 3]. The gene discussed is CA4; the disease is neoplasm.